Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,124 | -37,785 | -19,398 | -60,802 | -41,699 |
| Depreciation Amortization | -282 | -137 | -62 | 299 | 233 |
| Accounts payable and accrued liabilities | 948 | 3,067 | 358 | -194 | -206 |
| Other Working Capital | -2,810 | -87 | -1,832 | 7,674 | 2,639 |
| Other Operating Activity | 3,780 | -77 | 1,064 | 5,652 | 4,384 |
| Operating Cash Flow | $-53,488 | $-35,019 | $-19,870 | $-47,371 | $-34,649 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 35,609 | 32,101 | 12,817 | -16,988 | -18,580 |
| PPE Investments | -173 | -173 | -173 | -84 | -42 |
| Investing Cash Flow | $35,436 | $31,928 | $12,644 | $-17,072 | $-18,622 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,593 | 123 | 34 | 75,722 | 50,110 |
| Other Financing Activity | -9 | -1 | -1 | 0 | -2 |
| Financing Cash Flow | $9,584 | $122 | $33 | $75,722 | $50,108 |
| Beginning Cash Position | 35,389 | 35,389 | 35,389 | 24,110 | 24,110 |
| End Cash Position | 26,921 | 32,420 | 28,196 | 35,389 | 20,947 |
| Net Cash Flow | $-8,468 | $-2,969 | $-7,193 | $11,279 | $-3,163 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,488 | -35,019 | -19,870 | -47,371 | -34,649 |
| Capital Expenditure | -173 | -173 | -173 | -84 | -42 |
| Free Cash Flow | -53,661 | -35,192 | -20,043 | -47,455 | -34,691 |